Moderna’s mRNA-1273 Vaccine Put to Biggest Test
The experimental vaccine, mRNA-1273, is put to its biggest test as 30,000 American volunteers roll...
Read MoreJul 29, 2020
The experimental vaccine, mRNA-1273, is put to its biggest test as 30,000 American volunteers roll...
Read MoreJul 29, 2020
Moderna, Inc., a clinical stage biotechnology company pioneering messenger RNA (mRNA)...
Read MoreJul 29, 2020
Vaccine maker gets $472 million booster shot Moderna announced that it is moving into phase III...
Read MoreJul 29, 2020
Although racial minorities, older people and those with underlying medical conditions are most at risk from COVID-19, they’ve historically been the least likely to be included in clinical trials for treatments for serious diseases. Will that change with COVID-19?
Read MoreJul 27, 2020
The drug, either alone or in combination with azithromycin, failed to improve outcomes for...
Read MoreJul 26, 2020
FRIDAY, July 24, 2020 (HealthDay News) — The COVID-19 pandemic has had a considerable impact...
Read MoreJul 26, 2020
FRIDAY, July 24, 2020 (HealthDay News) — In the COVID-19 era, there has been a decrease in...
Read MoreJul 26, 2020
FRIDAY, July 24, 2020 (HealthDay News) — Mental health deteriorated in the United Kingdom by...
Read MoreJul 24, 2020
THURSDAY, July 23, 2020 (HealthDay News) — The median prevalence of any underlying medical...
Read MoreJul 24, 2020
THURSDAY, July 23, 2020 (HealthDay News) — For adults with invasive cancer and severe acute...
Read MoreJul 24, 2020
THURSDAY, July 23, 2020 (HealthDay News) — The nonreplicating adenovirus type-5...
Read MoreJul 24, 2020
‘Germicidal’ ultraviolet light technology has a proven track record against indoor transmission of tuberculosis and other airborne microbes. It’s now being used in some restaurants and on subways.
Read MoreJul 23, 2020
NIH is pulling out all stops with its RADx national testing program As director of the National...
Read MoreJul 23, 2020
The pandemic has given the National Institutes of Health an opportunity to show the value of its $1.5 billion “All of Us” research program. A major effort to make the platform’s database representative of America resulted in minorities making up more than half of its more than 270,000 volunteers.
Read MoreJul 22, 2020
Phase II trials from AstraZeneca, CanSino, and Pfizer poised to move on to phase III As the...
Read MoreJul 22, 2020
Case raises safety concerns about blood supply A case of detectable SARS-CoV-2 in a volunteer...
Read MoreJul 20, 2020
About 1,000 children worldwide have had the condition known as MIS-C — Multisymptom Inflammatory Syndrome in Children. Children’s hospitals around the U.S. are trying to keep tabs on young people after they recover from the ailment, to gauge any long-term effects.
Read MoreJul 18, 2020
FRIDAY, July 17, 2020 (HealthDay News) — Nearly all symptomatic COVID-19 patients experience...
Read MoreJul 18, 2020
FRIDAY, July 17, 2020 (HealthDay News) — Lopinavir/ritonavir (LPV/RTV) treatment of COVID-19...
Read MoreJul 18, 2020
FRIDAY, July 17, 2020 (HealthDay News) — The U.S. government should make immediate...
Read More